DarioHealth is a digital health company. Co.'s Digital Therapeutics products include the Dario Blood Glucose Monitoring System, the Dario Smart Diabetes Management Solution (provided to its users in the form of a smartphone application that enables the delivery of content and periodical evidence-based reports for its users to control and improve their diabetes), the DarioEngage platform (which provides support and two-way real-time connectivity between its users and their caregivers) and Dario Intelligence (which utilizes user data and is an analytics tool that can assist healthcare providers in the treatments and predictability of diseases). The DRIO stock yearly return is shown above.
The yearly return on the DRIO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2014 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the DRIO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|